Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells
2014 · Molecular Cancer · 80 citations
https://doi.org/10.1186/1476-4598-13-203
W
Wendan Yu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
66
Papers
2.2K
Citations
28
h-index
49
i10-index
Wendan Yu is an academic researcher from Dalian Medical University. The author has contributed to research in topics: RNA modifications and cancer & Inflammatory mediators and NSAID effects & Estrogen and related hormone effects. The author has an h-index of 28, co-authored 57 publications.
Papers by this author
worksTargeting HMGB3/hTERT axis for radioresistance in cervical cancer
2020 · Journal of Experimental & Clinical Cancer Research · 47 citations
https://doi.org/10.1186/s13046-020-01737-1
TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling
2014 · Molecular Cancer · 45 citations
https://doi.org/10.1186/1476-4598-13-89
YBX1 mediates autophagy by targeting p110β and decreasing the sensitivity to cisplatin in NSCLC
2020 · Cell Death and Disease · 43 citations
https://doi.org/10.1038/s41419-020-2555-4
Melatonin increases the chemosensitivity of diffuse large B-cell lymphoma cells to epirubicin by inhibiting P-glycoprotein expression via the NF-κB pathway
2020 · Translational Oncology · 28 citations
https://doi.org/10.1016/j.tranon.2020.100876
NMI inhibits cancer stem cell traits by downregulating hTERT in breast cancer
2017 · Cell Death and Disease · 26 citations
https://doi.org/10.1038/cddis.2017.200
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat